Rapporten

Dybdegående analyser af virksomhedsfinansiering, vækststrategier og markedsindsigt fra verdens mest innovative virksomheder

207 rapporter og tæller

Opdateret dagligt med den seneste markedsintelligens
HealthTech
Strand Therapeutics

Strand Therapeutics raises $153M Series B

Strand Therapeutics raises $153M in Series B. mRNA-based therapeutics developer with novel cancer treatment platform...

Editorial Team
Sep 17, 2025
0 min read$153M
Fundraising
Strand Therapeutics

Strand Therapeutics Raises $153M in Series B

Strand Therapeutics, a HealthTech company based in Cambridge, MA, has raised $153M in Series B led by Kinnevik, Regeneron Ventures, ICONIQ, Amgen Ventures.

Fundraising News Team
Aug 7, 2025
0 min read
Biotech
Strand Therapeutics

Strand Therapeutics Raises $153M Series B to Transform Biotech

Strand Therapeutics has secured $153M Series B in funding to accelerate growth and innovation in the biotech sector. Synthetic biology company programming mRNA therapies with logic-gated controls for precision oncology treatments...

David Chen
Oct 22, 2025
0 min read$153M Series B
HealthTech
Arnatar Therapeutics

Arnatar Therapeutics raises $52M Series A

Arnatar Therapeutics raises $52M in Series A. Developing therapeutics for autoimmune and inflammatory diseases...

Editorial Team
Aug 25, 2025
0 min read$52M
Biotech
Denali Therapeutics

Denali Therapeutics raises $217M Series C at $5B valuation

Denali Therapeutics raises $217M in Series C at $5B valuation. Neurodegeneration therapeutics...

Editorial Team
Mar 6, 2024
0 min read$217M
Biotech
Seres Therapeutics

Seres Therapeutics raises $113M Series E at $450M valuation

Seres Therapeutics raises $113M in Series E at $450M valuation. Microbiome therapeutic platform...

Editorial Team
Jan 19, 2024
0 min read$113M
Biotech
Crystalys Therapeutics

Crystalys Therapeutics raises $205M Series B at $900M valuation

Crystalys Therapeutics raises $205M in Series B at $900M valuation. Developing novel therapeutics for neurodegenerative diseases...

Editorial Team
Oct 1, 2025
0 min read$205M
Biotech
Kailera Therapeutics

Kailera Therapeutics raises $400M Series A at $1.5B valuation

Kailera Therapeutics raises $400M in Series A at $1.5B valuation. Developing obesity therapeutics with acquired pipeline...

Editorial Team
Oct 1, 2024
0 min read$400M
Biotech
Expedition Therapeutics

Expedition Therapeutics raises $165M Series B at $850M valuation

Expedition Therapeutics raises $165M in Series B at $850M valuation. Developing novel therapeutics for cardiometabolic diseases...

Editorial Team
Jan 15, 2025
0 min read$165M
Side 1

Viser 9 rapporter • Side 1 • Kategori: all

Hold dig foran markedet

Få ugentlig indsigt leveret til din indbakke. Ingen spam, kun intelligens.